Cure8 research brief
The study nominates specific compounds and molecular targets from a traditional herbal formulation that could be investigated as potential anti-inflammatory agents for ulcerative colitis, helping bridge chemical profiling with target-driven research.
Researchers, clinicians interested in complementary or herbal approaches to IBD, and drug-discovery teams
The authors identified 51 compounds in HQD and, by intersecting predicted compound targets with UC-related genes (including GEO data), derived 109 common targets. Enrichment analyses pointed to inflammatory and immune-related pathways; highlighted targets included NOS2, AHR, MMP3, MMP9, and PRKCQ.
Fifteen putative active constituents were quantified in HQD batches (baicalin was most abundant), and molecular docking predicted favorable binding for several compound–target pairs.
The study is an integrative, hypothesis-generating analysis combining chemical profiling, in silico target prediction, and docking rather than providing experimental efficacy or clinical outcomes.
Results are based on chemical profiling, bioinformatics, and molecular docking (in silico); they do not provide clinical evidence of benefit. The summary is based on the article abstract and provided text.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Patients and clinicians often ask whether herbal formulas or plant compounds can help IBD. This preclinical study identifies quercetin and the PI3K–Akt pathway as potential mechanisms, which may guide future research...
The study links a traditional herbal formula to improved colitis in mice and to changes in bile-acid metabolism through the FXR–FGF15 pathway, suggesting a mechanistic route that could inform future preclinical or...
The study identifies specific anti-inflammatory compounds in Artemisia scoparia and shows they reduce inflammation in cell and mouse models of ulcerative colitis, suggesting potential new leads for drug or...
